Cancer incidence and mortality in the European union: Cancer registry data and estimates of national incidence for 1990

European Journal of Cancer Part A

Volumn 33, Issue 7, 1997, Pages 1075-1107

  Black, R J ^a   Bray, F ^b   Ferlay, J ^a   Parkin, D M ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cancer registries; Epidemiology; Incidence; Mortality

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER REGISTRY; EUROPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFORMATION PROCESSING; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; EUROPE; EUROPEAN UNION; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; SEX DISTRIBUTION;

EID: 0030757461     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00492-3     Document Type: Article

References (81)

1. Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 1993, 55, 891-903.
2. European Commission. European Network of Cancer Registries. Luxembourg, Office for Official Publications of the European Communities, 1995.
3. European Network of Cancer Registries. EUROCIM User Manual, 2nd edn. Lyon, International Agency for Research on Cancer, 1995.
4. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993, 54, 594-606.
5. Møller Jensen O, Estève J, Møller H, Renard H. Cancer in the European Community and its member states. Eur J Cancer 1990, 26, 1167-1256.
6. Estève J, Kricker A, Ferlay J, Parkin DM. Facts and Figures of Cancer in the European Community. Lyon, International Agency for Research on Cancer, 1993.
7. Laplanche A, Benhamou E. Estimation of cancer incidence in France. Bull Cancer Paris 1991, 78, 405-414.
8. Raymond L, Bulliard JL, Levi F, et al. Estimating the incidence of cancers in Switzerland: 1983-1987. Eur J Cancer 1994, 30A, 978-982.
9. Verdecchia A, Capocaccia R, Chessa E, De Angelis G, Micheli A, Valente F. Incidence and prevalence of respiratory tumors in Italy. Estimation from mortality data. Ann 1st Super Sanita 1992, 28, 91-105.
10. Capocaccia R, Verdecchia A, Micheli A, Sant M, Gatta G, Berrino F. Breast cancer incidence and prevalence estimated from survival and mortality. Cancer Causes Control 1990, 1, 23-29.
11. Micheli A, Verdecchia A, Capocaccia R, et al. Estimated incidence and prevalence of female breast cancer in Italian regions. Tumori 1992, 78, 13-21.
12. Negri E, La Vecchia C, Franceschi S, Levi F. Patterns of mortality from major cancers in Europe. Cancer Epidemiol Biomakers Prev 1994, 3, 531-536.
13. Coleman MP, Estève J, Damiecki P, Arslan A, Renard H. Trends in Cancer Incidence and Mortality. IARC Scientific Publications No 121. Lyon, International Agency for Research on Cancer, 1993.
14. Ferlay J, Black RJ, Pisani P, Valdivieso MT, Parkin DM. EUCan90: Cancer in the European Union. IARC Cancer Base No. 1. Lyon, International Agency for Research on Cancer, 1996.
15. Österreichisches Krebsregister (Austrian Cancer Registry). Krebskrankenstatistik. Wein, Österreichisches Statistisches Zentralamt, 1992.
16. Storm HH, Manders T, Friis S, Brandt B. Cancer Incidence in Denmark 1990. Copenhagen, Danish Cancer Society, 1994.
17. The Finnish Cancer Registry. Cancer Incidence in Finland in 1989 and 1990. Helsinki, Institute for Statistical and Epidemiological Cancer Research, 1992.
18. Visser O, Coebergh JWW, Schouten LJ. Incidence of Cancer in The Netherlands in 1990. Second Report of The Netherlands Cancer Registry. Utrecht, Netherlands Cancer Registry, 1993.
19. Swedish Cancer Registry. Cancer Incidence in Sweden 1990. Copenhagen, The National Board of Health and Welfare, 1993.
20. Estève J, Benhamou E, Raymond L. Statistical Methods in Cancer Research, Volume IV. Descriptive Epidemiology. IARC Scientific Publications No 128. Lyon, International Agency for Research on Cancer, 1994.
21. Capocaccia R, Valente F, Verdecchia A. The incidence and prevalence of chronic diseases estimated from mortality data. Epidemiol Prev 1991, 13, 38-49.
22. Capocaccia R. Relationships between incidence and mortality in non-reversible diseases. Stat Med 1993, 12, 2395-2415.
23. Berrino F, Sant M, Verdecchia R, Capocaccia R, Hakulinen T, Estève J (eds). Survival of Cancer Patients in Europe. The EUROCARE Study. IARC Scientific Publications No 132. Lyon, International Agency for Research on Cancer, 1995.
24. Francis B, Green M, Payne C (eds). The GLIM System. Release 4 Manual. Oxford, Clarendon Press, 1993.
25. Boyle P, Macfarlane GJ, Blot WJ, et al. European School of Oncology Advisory report to the European Commission for the Europe Against Cancer Programme: oral carcinogenesis in Europe. Eur J Cancer B, Oral Oncol 1995, 31B, 75-85.
26. La Vecchia C, Franceschi S, Levi F, Lucchini F, Negri E. Diet and human oral carcinoma in Europe. Eur J Cancer B, Oral Oncol 1993, 29B, 17-22.
27. Cheng KK, Day NE, Davies TW. Oesophageal cancer mortality in Europe: paradoxical time trend in relation to smoking and drinking. Br J Cancer 1992, 65, 613-617.
28. Smans M, Muir CS, Boyle P (eds). Atlas of Cancer Mortality in the European Economic Community. IARC Scientific Publication No 107. Lyon, International Agency for Research on Cancer, 1992.
29. Correa P, Chen VW. Gastric cancer. Cancer Surv 1994, 19-20, 55-76.
30. The EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993, 341, 1359-1362.
31. International Agency for Research on Cancer (IARC). Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol 61. Schistosomes, Liver Flukes and Heliocobacter Pylori. Lyon, International Agency for Research on Cancer, 1994.
32. Miller AB, Berrino F, Hill M, Pietinen R, Riboli E, Wahrendorf J. Diet in the aetiology of cancer: a review. Eur J Cancer 1994, 30A, 207-220.
33. Møller Jensen O. Different age and sex relationship for cancer of subsites of the large bowel. Br J Cancer 1984, 50, 825-829.
34. Newcomb PA, Storer BE. Postmenopausal hormone use and risk of large-bowel cancer. J Natl Cancer Inst 1995, 87, 1067-1071.
35. International Agency for Research on Cancer (IARC). Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol 59. Hepatitis Viruses. Lyon, International Agency for Research on Cancer, 1994.
36. Parkin DM, Pisani P, Lopez AD, Masuyer E. At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer 1994, 59, 494-504.
37. Howe GR, Ghadirian P, Bueno de Mesquita HB. A collaborative case-control study of nutrient intake and pancreatic cancer within the SEARCH programme. Int J Cancer 1992, 51, 365-372.
38. Tuyns AJ, Estève J, Raymond L, et al. Cancer of the larynx/ hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France). Int J Cancer 1988, 41, 483-491.
39. Sancho Gamier H, Theobald S. Black (air-cured) and blond (flue-cured) tobacco and cancer risk II: pharynx and larynx cancer. Eur J Cancer 1993, 29A, 273-276.
40. International Agency for Research on Cancer (IARC). Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 38. Tobacco Smoking. Lyon, International Agency for Research on Cancer, 1986.
41. Armstrong BK, Kricker A. Cutaneous melanoma. Cancer Surv 1994, 19-20, 219-240.
42. Kelsey JL, Gammon MD. Epidemiology of breast cancer. Epidemiol Rev 1990, 12, 228-240.
43. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993, 15, 36-47.
44. Brinton LA, Daling JR, Liff JM, et al. Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst 1995, 87, 827-835.
45. Parkin DM. Cancers of the breast, endometrium and ovary: geographic correlations. Eur J Cancer 1989, 25, 1917-1925.
46. McMichael AJ, Giles GG. Cancer in migrants to Australia: extending the descriptive epidemiological data. Cancer Res 1988, 48, 751-756.
47. Riboli E. Nutrition and cancer: background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC). Ann Oncol 1992, 3, 783-791.
48. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992, 339, 1-15.
49. International Agency for Research on Cancer (IARC). Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol 64. Human Papillomaviruses. Lyon, International Agency for Research on Cancer, 1995.
50. Beral V, Hermon C, Munoz N, Devesa SS. Cervical cancer. Cancer Surv 1994, 19-20, 265-285.
51. Parkin DM, Nguyen-Dinh X, Day NE. The impact of screening on the incidence of cervical cancer in England and Wales. Br J Obstet Gynaecol 1985, 92, 150-157.
52. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1987, 1, 1247-1249.
53. Ponten J, Adami HO, Bergstrom R, et al. Strategies for global control of cervical cancer. Int J Cancer 1995, 60, 1-26.
54. La Vecchia C. Nutritional factors and cancers of the breast, endometrium and ovary. Eur J Cancer Clin Oncol 1989, 25, 1945-1951.
55. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995, 85, 304-313.
56. Cancer and Steroid Hormone Study. Combination oral contraceptive use and the risk of endometrial cancer. JAMA 1987, 257, 796-800.
57. Adami HO, Hsieh CC, Lambe M, et al. Parity, age at first childbirth, and risk of ovarian cancer. Lancet 1994, 344, 1250-1254.
58. Cancer and Steroid Hormone Study. The reduction in risk of ovarian cancer associated with oral contraceptive use. N Engl J Med 1987, 316, 650-655.
59. Adami HO, Bergstrom R, Persson I, Sparen P. The incidence of ovarian cancer in Sweden, 1960-1984. Am J Epidemiol 1990, 132, 446-452.
60. dos Santos Silva I, Swerdlow AJ. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use. Br J Cancer 1995, 72, 485-492.
61. Whittemore AS. Prostate cancer. Cancer Surv 1994, 19-20, 309-322.
62. Thune I, Lund E. Physical activity and the risk of prostate and testicular cancer: a cohort study of 53,000 Norwegian men. Cancer Causes Control 1994, 5, 549-556.
63. United Kingdom Testicular Cancer Study Group. Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise. Br Med J 1994, 308, 1393-1399.
64. Giwercman A, Carlsen E, Keiding N, Skakkebaek NE. Evidence for increasing incidence of abnormalities of the human testis: a review. Environ Health Perspect 1993, 101(Suppl 2), 65-71.
65. Moøller H. Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur Urol 1993, 23, 8-13.
66. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J (eds). Cancer Incidence in Five Continents, Volume VI. IARC Scientific Publications No 120. Lyon, International Agency for Research on Cancer, 1992.
67. Vineis P. Black (air-cured) and blond (flue-cured) tobacco and cancer risk. I: Bladder cancer. Eur J Cancer 1991, 27, 1491-1493.
68. McCredie M. Bladder and kidney cancers. Cancer Surv 1994, 19-20, 343-368.
69. Vineis P, Simonato L. Proportion of lung and bladder cancers in males resulting from occupation: a systematic approach. Arch Environ Health 1991, 46, 6-15.
70. Davis DL, Ahlbom A, Hoel D, Percy C. Is brain cancer mortality increasing in industrial countries? Am J Ind Med 1991, 19, 421-431.
71. Franceschi S, Boyle P, Maisonneuve P, et al. The epidemiology of thyroid carcinoma. Crit Rev Oncol 1993, 4, 25-52.
72. Langsteger W, Koltringer P, Wolf G, et al. The impact of geographical, clinical, dietary and radiation-induced features in epidemiology of thyroid cancer. Eur J Cancer 1993, 29A, 1547-1553.
73. Kinlen LJ. Malignancy in autoimmune diseases. J Autoimmun 1992, 5(Suppl A), 363-371.
74. Obrams GI, Grufferman S. Epidemiology of HIV associated non-Hodgkin's lymphoma. Cancer Surv 1991, 10, 91-102.
75. MacMahon B. Epidemiology of Hodgkin's disease. Cancer Res 1966, 26, 1189-1201.
76. Evans AS, Mueller NE. Viruses and Cancer. Causal Associations. Ann Epidemiol 1990, 1, 71-92.
77. Cuzick J. Multiple myeloma. Cancer Surv 1994, 19-20, 455-474.
78. Linet, MS. The Leukaemias: Epidemiological Aspects. Monographs on Epidemiology and Biostatistics Volume 6. New York, Oxford University, 1985.
79. Alexander FE. Viruses, clusters and clustering of childhood leukaemia: a new perspective? Eur J Cancer 1993, 29A, 1424-1443.
80. Storm HH, Clemmensen IH, Black RJ. Survey of Cancer Registries in the European Union. Part I: Scope and Methods of Data Collection. IARC Technical Report No 28. Lyon, International Agency for Research on Cancer, in press.
81. Percy C, Muir C. The international comparability of cancer mortality data. Results of an international death certificate study. Am J Epidemiol 1989, 129, 934-946.